Cited by 666Adipokines, Inflammation, and Metabolic DiseasesPeroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism

Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation

Open access
Fu, Yuchang, Luo, Nanlan, Klein, Richard L., Garvey, W. Timothy·2005·Journal of Lipid Research

Abstract

Adiponectin is secreted from adipocytes, and low circulating levels have been epidemiologically associated with obesity, insulin resistance, type 2 diabetes, and cardiovascular disease. To investigate whether adiponectin could exert autocrine effects in adipocytes, we expressed the adiponectin gene in 3T3-L1 fibroblasts. We observed that 3T3-L1 fibroblasts expressing adiponectin have a fast growth phase and reach confluence more rapidly compared with control cells or LacZ-transduced cells. Furthermore, cells with overexpressed adiponectin were observed to differentiate into adipocytes more rapidly, and during adipogenesis, they exhibited more prolonged and robust gene expression for related transcriptional factors, CCAAT/enhancer binding protein alpha (C/EBP2), peroxisome proliferator-activated receptor gamma (PPARgamma), and adipocyte determination and differentiation factor 1/sterol-regulatory element binding protein 1c (ADD1/SREBP1c) and earlier suppression of PPARgamma coactivator-1alpha (PGC-1alpha). In fully differentiated adipocytes, adiponectin-overexpressing cells accumulated more and larger lipid droplets compared with control cells. Also, adiponectin increased insulin's ability to maximally stimulate glucose uptake by 78% through increased glucose transporter 4 (GLUT4) gene expression and increased GLUT4 recruitment to the plasma membrane. These data suggest a new role for adiponectin as an autocrine factor in adipose tissues: promoting cell proliferation and differentiation from preadipocytes into adipocytes, augmenting programmed gene expression responsible for adipogenesis, and increasing lipid content and insulin responsiveness of the glucose transport system in adipocytes.

Integrity signals

Registry

Crossref · 10.1194/jlr.m400373-jlr200

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Adiponectin is an adipocyte-secreted protein with neuroprotective effects, as well as insulin-sensitizing, anti-inflammatory and anti-atherogenic effects.

    “Adiponectin is an adipocyte-secreted protein that seems to have neuroprotective effects151, in addition to its insulin-sensitizing, anti-inflammatory and anti-atherogenic effects151,153.”

    From Exerkines in health, resilience and disease (2022) · cites this paper as [153]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fu, Y., Luo, N., Klein, R. L., & Garvey, W. T.
Affiliations
  • University of Alabama at Birmingham (US)
  • Medical University of South Carolina (US)
Corresponding author
Fu, Yuchang
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2005-07
Volume
46
Issue
7
Pages
1369-1379
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2134100561
Cited by
666
References
55
Citations by year
2026: 17 · 2025: 26 · 2024: 26 · 2023: 40 · 2022: 42 · 2021: 44 · 2020: 37 · 2019: 33 · 2018: 35 · 2017: 30 · 2016: 35 · 2015: 30 · 2014: 36 · 2013: 34 · 2012: 30
FWCI
20.32
Type
journal article
Language
en
Open access
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (5p01hl055782-10)
  • National Heart, Lung, and Blood Institute (P01 HL 55782)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 38764)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
adiponectin, adipogenesis, insulin sensitivity, lipid accumulation, autocrine signaling, 3T3-L1 fibroblasts, PPARγ, SREBP-1c, PGC-1α, GLUT4, glucose uptake, adipocyte proliferation, obesity, type 2 diabetes
MeSH terms
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Carrier Proteins, Cell Differentiation, DNA-Binding Proteins, Insulin, Insulin Resistance, Monosaccharide Transport Proteins, Muscle Proteins, Transcription Factors, Trans-Activators, Adipocytes, CCAAT-Enhancer-Binding Proteins, CCAAT-Enhancer-Binding Protein-alpha, Intercellular Signaling Peptides and Proteins, 3T3-L1 Cells, PPAR gamma, Lipid Metabolism, Fatty Acid-Binding Proteins, Glucose Transporter Type 4, Mice, Sterol Regulatory Element Binding Protein 1, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review